Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors

PHASE3CompletedINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

December 31, 2008

Conditions
Respiratory Tract Infection
Interventions
DIETARY_SUPPLEMENT

COLD-fX natural health product

200 mg/COLD-fX natural health product - 2 capsules twice daily for 6 months

DIETARY_SUPPLEMENT

COLD-fX

400 mg COLD-fX natural health product 2 times daily for 6 months

OTHER

Placebo

crystalline substance 200 mg twice daily for 6 months

Trial Locations (5)

T5M 3Z7

Alberta Health Services, Edmonton

Unknown

UBC Gerontology and Diabetes Research, Vancouver

IWK Health Centre, Halifax

Sunnybrook Health Sciences Centre, Toronto

Dr. Albert Osterhaus, Rotterdam

All Listed Sponsors
collaborator

Afexa Life Sciences Inc

INDUSTRY

collaborator

IWK Health Centre

OTHER

collaborator

Sunnybrook Health Sciences Centre

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

University of BC Gerontology & Diabetes Research

OTHER

lead

Capital Health, Canada

OTHER